<DOC>
	<DOCNO>NCT00512187</DOCNO>
	<brief_summary>The study hypothesis investigate whether moderate weight loss ( i.e . weight reduction least 5 % ) could improve response rate suboptimal dose cyclosporine patient severe psoriasis .</brief_summary>
	<brief_title>Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive Sub-Optimal Dose Cyclosporine : Investigator Blinded , Controlled , Randomized Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>18 year age , active clinically stable plaque psoriasis involve least 10 percent body surface area psoriasis area severity index ( PASI ) score ≥10 body mass index ≥30 . Other type psoriasis ( guttate , erythrodermic pustular psoriasis ) Uncontrolled hypertension Severe congestive heart failure Renal liver impairment Active chronic infection , include HIV , HBV HCV infection , latent tuberculosis Previous active malignancy Pregnancy lactation Previous treatment cyclosporine Phototherapy systemic topical therapy psoriasis within previous 4 week enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>